In Vitro Pharmacodynamic Characteristics of Amphotericin B, Caspofungin, Fluconazole, and Voriconazole against Bloodstream Isolates of Infrequent Candida Species from Patients with Hematologic Malignancies
Open Access
- 1 November 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (11) , 4453-4456
- https://doi.org/10.1128/aac.48.11.4453-4456.2004
Abstract
Time-kill and postantifungal effect (PAFE) of amphotericin B, caspofungin, fluconazole, and voriconazole were determined against clinical isolates of Candida guilliermondii, Candida kefyr, and Candida lusitaniae. Azoles displayed fungistatic activity and no measurable PAFE, regardless of the concentration tested. Amphotericin B and caspofungin demonstrated concentration-dependent fungicidal activity, although amphotericin B only produced a significant dose-dependent PAFE against all isolates tested.Keywords
This publication has 23 references indexed in Scilit:
- Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agentsJournal of Antimicrobial Chemotherapy, 2004
- In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agentsDiagnostic Microbiology and Infectious Disease, 2004
- Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A2 Reference Method for Testing New Antifungal Agents against Clinical Isolates of Candida sppJournal of Clinical Microbiology, 2004
- Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999Diagnostic Microbiology and Infectious Disease, 2004
- In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Evaluation of Etest Method for Determining Fluconazole and Voriconazole MICs for 279 Clinical Isolates of Candida Species Infrequently Isolated from BloodJournal of Clinical Microbiology, 2003
- In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from BloodJournal of Clinical Microbiology, 2003
- New Automated Method for Determining Postantifungal Effect of Amphotericin B againstCandidaSpecies: Effects of Concentration, Exposure Time, and Area under the CurveAntimicrobial Agents and Chemotherapy, 2002
- Postantifungal Effects of Echinocandin, Azole, and Polyene Antifungal Agents against Candida albicans and Cryptococcus neoformansAntimicrobial Agents and Chemotherapy, 2000
- The postantibiotic effect of antifungal agents against common pathogenic yeastsJournal of Antimicrobial Chemotherapy, 1994